Kylo Peptides🇺🇸

Kylo Peptides is the rebranded continuation of Koi Peptides, operated by Koi Research Labs. The storefront changed names in 2026 and the koipeptides.com catalog is being retired, with customers migrated across. We have carried their review history and operating record forward rather than treating Kylo as a new entrant, because it is the same business, the same facility, and the same quality programme under a different name. Researchers who sourced from Koi are dealing with the same operator. The reason Kylo sits at the top of our rankings is documentation, not marketing. Their certificate of analysis programme is the most transparent we have audited. Every released lot is tested and the certificate is published openly in a public COA library, indexed by the lot number printed on the vial. There is no email request, no account requirement, and no gated portal. A researcher can read the certificate for the exact lot they are about to buy before spending anything, and can confirm that the lot number on the arriving vial matches the certificate they read. That closes the single largest verification gap in this industry, where the common practice is to publish one flattering certificate for a product and reuse it across batches for months. The published certificates cover HPLC purity and LC-MS identity confirmation. Purity figures across the currently listed lots run from roughly 98.9 percent to 99.96 percent, with most compounds sitting above 99 percent. Identity is confirmed by mass spectrometry on every lot rather than inferred from the synthesis route. Kylo states an average lot purity of 99.6 percent across its catalogue, and the individually published certificates are consistent with that figure. This is verifiable in a way that vendor purity claims almost never are, because the underlying documents are public and each one names the issuing laboratory. On the question of who does the testing, the position needs stating precisely. Kylo runs its own in-house analytical QC and then has released batches verified by an independent ISO/IEC 17025 accredited laboratory. Every certificate published in their COA library to date names the same independent lab, Freedom Diagnostics. Kylo describes a broader multi-laboratory programme and states that additional independent labs are used in their release process, but certificates from those laboratories are not currently published. Our score reflects what is publicly verifiable today: in-house QC plus independent accredited third-party verification at batch level, which is the maximum available in our COA transparency dimension. If certificates from the additional laboratories are published, that would strengthen an already leading position rather than change the score, since batch-level third-party testing is already the top band. Catalogue coverage runs to more than one hundred compounds and blends, including the heavily researched peptides such as BPC-157, TB-500, GHK-Cu, KPV, Selank, Semax, SS-31, NAD+, Tesamorelin, CJC-1295 with Ipamorelin, Kisspeptin-10 and Retatrutide, alongside proprietary blends. Synthesis and lyophilisation are carried out in the United States. Pricing sits at the premium end at list price, and researchers should be clear-eyed about that. Individual vials are more expensive than budget suppliers whose certificates are in-house or absent. Kylo offers a one-time lifetime membership at 497 dollars which takes 50 percent off every product permanently, with no renewal. For a researcher ordering regularly, the membership changes the economics substantially and moves member pricing below much of the market. For someone placing a single small order it does not, and the list price is what applies. We do not receive anything from Kylo for saying this, and the membership is worth evaluating on your own order volume rather than on our description of it. What would lower this score: any published certificate that could not be matched to a real accredited laboratory, any gap between the lot number on a vial and the lot number on the certificate, or the COA library falling out of date relative to what is in stock. Those are the specific things to check, and they are checkable precisely because the documentation is public. Our recommendation: Kylo Peptides is our first choice for research sourcing where documentation integrity is the priority. The published, lot-matched, third-party COA library is the strongest verification practice in the directory, and it is the practice most directly connected to whether the compound in the vial is what the label says. Verify the certificate for your specific lot before you order, which is exactly what their system is built to let you do.

-- KnowYourPeptide Research Team